Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials

BackgroundSeveral trials have considered the safety and clinical benefits of colchicine as a treatment option for secondary prevention in patients with coronary atherosclerotic heart disease (CAD), but its safety and clinical benefits remain controversial. The purpose of this study was to explore th...

Full description

Bibliographic Details

Published in:	Frontiers in Cardiovascular Medicine
Main Authors:	Zijun Ma, Jun Chen, Kaiqin Jin, Xin Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Subjects:	coronary heart disease secondary prevention colchicine dose randomized controlled trial
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.947959/full